The top 10 HealthTech M&A deals (by deal size) range from EUR 3.96bn to EUR 667m, with an average deal size of EUR 1.46bn. All top 10 targets were headquartered in the US. The largest deal was the acquisition of Change Healthcare by McKesson in June 2016 for EUR 3.96bn.
Compared to the average deal sizes of the previous top 10 M&A rankings in Biotech (EUR 32bn) and MedTech (EUR 11bn), the top 10 HealthTech M&A ranking recorded the smallest average deal size (EUR 1.46bn).
About FCF Life Sciences
FCF Life Sciences advises leading healthcare companies in Europe on financing transactions (equity, debt, and licensing) with regional and international investors. Our team consists of science-driven industry and finance experts with a strong track record in managing financing processes. We thrive to maximize the efficiency in the fundraising process and increase its closing probability.
Learn more about FCF Life Sciences, click here.
We closely track the activity in the financial markets and are passionate about capital markets research. Not every idea or research question make it into the final selection for our publications. However, we generate interesting information on financing trends in Life Sciences sector, which we would like to share in our blog.
To hear from us on the latest insights, please sign up here: